Novogen Announces Preclinical Studies Justifies Mode Of Delivery And Dosing Regimen For Anisina

By: via Benzinga
US-Australian drug discovery company, Novogen Limited (NASDAQ: NVGN), today announced details of preclinical studies which confirm the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.